Close

Aligos Therapeutics Inc. (ALGS) Begins First Cohort Dosing in Ongoing Phase 1 PoC Study Evaluating ALG-000184

Go back to Aligos Therapeutics Inc. (ALGS) Begins First Cohort Dosing in Ongoing Phase 1 PoC Study Evaluating ALG-000184
(NASDAQ: ALGS) Delayed: 0.98 --0 (-0%)
Previous Close $0.98    52 Week High
Open $0.98    52 Week Low
Day High $0.98    P/E N/A 
Day Low $0.98    EPS
Volume 5,326